Novel theranostic proceed for treating pancreatic cancer patients shows promise

Amadeo03 May, 2018Health

In early preclinical studies with animal models, a novel procession significantly indifferent expansion growth. Focusing on a neurotensin receptor 1 (NTR1), a protein that is overexpressed in ductal pancreatic adenocarcinoma, researchers grown a DOTA-conjugated NTR1 criminal 3BP-227 labeled with a radioisotope lutetium-177 (177Lu) to yield and guard therapy. For this study, 6 patients with reliable